TY - JOUR
T1 - The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
AU - Local Burden of Disease 2019 Neglected Tropical Diseases Collaborators
AU - Deshpande, Aniruddha
AU - Miller-Petrie, Molly K.
AU - Johnson, Kimberly B.
AU - Abdoli, A.
AU - Abrigo, Michael R.M.
AU - Adekanmbi, Victor
AU - Adetokunboh, Olatunji O.
AU - Adinarayanan, S.
AU - Ahmadpour, E.
AU - Ahmed, Muktar Beshir
AU - Akalu, Temesgen Yihunie
AU - Alanzi, T. M.
AU - Alinia, C.
AU - Alipour, Vahid
AU - Amit, Arianna Maever L.
AU - Anber, N. H.
AU - Ancuceanu, R.
AU - Andualem, Z.
AU - Ansari, F.
AU - Antonio, Carl Abelardo T.
AU - Anvari, D.
AU - Appiah, S.
AU - Arabloo, Jalal
AU - Arnold, B. F.
AU - Ausloos, Marcel
AU - Ayanore, Martin Amogre
AU - Badirzadeh, A.
AU - Baig, A. A.
AU - Banach, Maciej
AU - Baraki, A. G.
AU - Bärnighausen, Till Winfried
AU - Bayati, Mohsen
AU - Bhattacharyya, Krittika
AU - Bhutta, Zulfiqar A.
AU - Bijani, Ali
AU - Bockarie, M. J.
AU - Bisanzio, D.
AU - Biswas, Raaj Kishore
AU - Bohlouli, Somayeh
AU - Cano, Jorge
AU - Carvalho, Felix
AU - Chattu, Vijay Kumar
AU - Chavshin, C.
AU - Cormier, Natalie Maria
AU - Cromwell, Elizabeth A.
AU - Schmidt, C. A.
AU - Kwong, K. T.
AU - Damiani, G.
AU - Dandona, Rakhi
AU - Dandona, Lalit
AU - Darwesh, Aso Mohammad
AU - Daryani, Ahmad
AU - Dash, Aditya Prasad
AU - Deribe, Kebede
AU - Dessu, B.
AU - Dhimal, Meghnath
AU - Dianatinasab, M.
AU - Diaz, Daniel
AU - Do, Hoa Thi
AU - Earl, L.
AU - El Tantawi, Maha
AU - Faraj, A.
AU - Fattahi, N.
AU - Fernandes, Eduarda
AU - Fischer, Florian
AU - Foigt, Nataliya A.
AU - Foroutan, Masoud
AU - Guo, Yuming
AU - Hailu, G. B.
AU - Hasaballah, Ahmed I.
AU - Hassankhani, H.
AU - Herteliu, Claudiu
AU - de Hidru, Hagos Degefa
AU - Hon, J.
AU - Hole, M. K.
AU - Hossain, Naznin
AU - Hosseinzadeh, Mehdi
AU - Househ, Mowafa
AU - Humayun, Ayesha
AU - Ilesanmi, Olayinka Stephen
AU - Ilic, Milena D.
AU - Iqbal, Usman
AU - Irvani, Seyed Sina Naghibi
AU - Islam, Sheikh Mohammed Shariful
AU - Jha, Ravi Prakash
AU - Ji, John S.
AU - Jozwiak, Jacek Jerzy
AU - Kabir, Ali
AU - Kalankesh, L. R.
AU - Kalhor, R.
AU - Karami Matin, B.
AU - Karch, André
AU - Karimi, S.
AU - Kasaeian, Amir
AU - Kazemi Karyani, A.
AU - Kayode, Gbenga A.
AU - Kelbore, A. G.
AU - Khafaie, Morteza Abdullatif
AU - Khalilov, Rovshan
AU - Khan, Junaid
AU - Khatab, Khaled
AU - Khater, Mona M.
AU - Khodayari, M.
AU - Kim, Yun Jin
AU - King, J. D.
AU - Kinyoki, D. K.
AU - Kianipour, N.
AU - Kumar, G. Anil
AU - Kusuma, Dian
AU - La Vecchia, Carlo
AU - Lansingh, Van Charles
AU - Lee, Paul H.
AU - LeGrand, Kate E.
AU - Levine, Aubrey J.
AU - Li, Shanshan
AU - Maleki, S.
AU - Mansournia, Mohammad Ali
AU - Martins-Melo, Francisco Rogerlândio
AU - Massenburg, B. B.
AU - Mayala, Benjamin K.
AU - Meitei, W. B.
AU - Mendoza, Walter
AU - Mengistu, D. T.
AU - Mereta, Seid Tiku
AU - Mestrovic, Tomislav
AU - Mihretie, K. M.
AU - Mohammadian-Hafshejani, A.
AU - Mohammed, Shafiu
AU - Mokdad, Ali H.
AU - Moradi, Masoud
AU - Moradzadeh, R.
AU - Moraga, Paula
AU - Morrison, S. D.
AU - Mosser, Jonathan F.
AU - Mousavi, Seyyed Meysam
AU - Munro, Sandra B.
AU - Mupfasoni, D.
AU - Muthupandian, Saravanan
AU - mwingira, U. J.
AU - Naderi, Mehdi
AU - Nagarajan, Ahamarshan Jayaraman
AU - Naik, Gurudatta
AU - Negoi, Ionut
AU - Nguyen, Huong Lan Thi
AU - Nguyen, T. H.
AU - Olagunju, Andrew T.
AU - Omar Bali, A.
AU - Osarenotor, Osayomwanbo
AU - Osei, Frank B.
AU - Pasupula, D.
AU - Pigott, David M.
AU - Shirude, S.
AU - Hill, E.
AU - Donkers, K. M.
AU - Pirsaheb, Meghdad
AU - Pourjafar, H.
AU - Rawaf, Salman
AU - Rawaf, D. L.
AU - Rawassizadeh, R.
AU - Rezapour, A.
AU - Ribeiro, Ana Isabel
AU - Rostami, A.
AU - Sabesan, S.
AU - Sadeghi, Ehsan
AU - Sajadi, S. Mohammad
AU - Samy, Abdallah M.
AU - Sartorius, Benn
AU - Schaeffer, Lauren E.
AU - Shaikh, Masood Ali
AU - Sharafi, Kiomars
AU - Soltani, S.
AU - Sharifi, H.
AU - Shibuya, K.
AU - Shin, Jae Il
AU - Soheili, A.
AU - Spotin, A.
AU - Stolk, W. A.
AU - Tesfay, Berhe Etsay
AU - Topor-Madry, Roman
AU - Tran, Bach Xuan
AU - Tran, Khanh Bao
AU - Ullah, Irfan
AU - Unnikrishnan, Bhaskaran
AU - Vasseghian, Y.
AU - Violante, Francesco S.
AU - Vinkeles Melchers, N. V.S.
AU - Yamada, Tomohide
AU - Yaya, S.
AU - Yazdi-Feyzabadi, V.
AU - Yip, Paul
AU - Yonemoto, Naohiro
AU - Zaki, L.
AU - Zaman, Sojib Bin
AU - Zamanian, M.
AU - Zangeneh, A.
AU - Zhang, Yunquan
AU - Zhang, Z.
AU - Ziapour, Arash
AU - Hay, Simon I.
AU - Reiner, Robert C.
N1 - Publisher Copyright:
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Background:
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to eliminate lymphatic filariasis as a public health problem. This study aims to produce the first geospatial estimates of the global prevalence of lymphatic filariasis infection over time, to quantify progress towards elimination, and to identify geographical variation in distribution of infection.
Methods:
A global dataset of georeferenced surveyed locations was used to model annual 2000–18 lymphatic filariasis prevalence for 73 current or previously endemic countries. We applied Bayesian model-based geostatistics and time series methods to generate spatially continuous estimates of global all-age 2000–18 prevalence of lymphatic filariasis infection mapped at a resolution of 5 km2 and aggregated to estimate total number of individuals infected.
Findings:
We used 14 927 datapoints to fit the geospatial models. An estimated 199 million total individuals (95% uncertainty interval 174–234 million) worldwide were infected with lymphatic filariasis in 2000, with totals for WHO regions ranging from 3·1 million (1·6–5·7 million) in the region of the Americas to 107 million (91–134 million) in the South-East Asia region. By 2018, an estimated 51 million individuals (43–63 million) were infected. Broad declines in prevalence are observed globally, but focal areas in Africa and southeast Asia remain less likely to have attained infection prevalence thresholds proposed to achieve local elimination.
Interpretation:
Although the prevalence of lymphatic filariasis infection has declined since 2000, MDA is still necessary across large populations in Africa and Asia. Our mapped estimates can be used to identify areas where the probability of meeting infection thresholds is low, and when coupled with large uncertainty in the predictions, indicate additional data collection or intervention might be warranted before MDA programmes cease. Funding: Bill & Melinda Gates Foundation.
AB - Background:
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to eliminate lymphatic filariasis as a public health problem. This study aims to produce the first geospatial estimates of the global prevalence of lymphatic filariasis infection over time, to quantify progress towards elimination, and to identify geographical variation in distribution of infection.
Methods:
A global dataset of georeferenced surveyed locations was used to model annual 2000–18 lymphatic filariasis prevalence for 73 current or previously endemic countries. We applied Bayesian model-based geostatistics and time series methods to generate spatially continuous estimates of global all-age 2000–18 prevalence of lymphatic filariasis infection mapped at a resolution of 5 km2 and aggregated to estimate total number of individuals infected.
Findings:
We used 14 927 datapoints to fit the geospatial models. An estimated 199 million total individuals (95% uncertainty interval 174–234 million) worldwide were infected with lymphatic filariasis in 2000, with totals for WHO regions ranging from 3·1 million (1·6–5·7 million) in the region of the Americas to 107 million (91–134 million) in the South-East Asia region. By 2018, an estimated 51 million individuals (43–63 million) were infected. Broad declines in prevalence are observed globally, but focal areas in Africa and southeast Asia remain less likely to have attained infection prevalence thresholds proposed to achieve local elimination.
Interpretation:
Although the prevalence of lymphatic filariasis infection has declined since 2000, MDA is still necessary across large populations in Africa and Asia. Our mapped estimates can be used to identify areas where the probability of meeting infection thresholds is low, and when coupled with large uncertainty in the predictions, indicate additional data collection or intervention might be warranted before MDA programmes cease. Funding: Bill & Melinda Gates Foundation.
UR - https://www.scopus.com/pages/publications/85089498203
U2 - 10.1016/S2214-109X(20)30286-2
DO - 10.1016/S2214-109X(20)30286-2
M3 - Article
C2 - 32827480
AN - SCOPUS:85089498203
SN - 2572-116X
VL - 8
SP - e1186-e1194
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 9
ER -